AIM: To explore the expression and clinicopathological significance of cyclooxygenase-2 (COX-2) and microvessel density (MVD) in gastric carcinogenesis, and to investigate their roles in the invasion and the relationship between biological behaviors and prognosis of gastric cancer. METHODS: Using Envision immunohistochemistry, COX-2 and CD34 expressions in gastric cancer tissue array were examined. MVD was counted and the relationship between the biological behaviors and prognosis was analyzed. RESULTS: The expression of COX-2 in gastric cancer tissue was significantly higher than that in normal mucosa (c2 = 12.191, P < 0.05). The over-expression of COX-2 in gastric cancer was obviously related to metastasis and depth of invasion (c2 = 6.315, P < 0.05), but not related to the histological type and Borrmann type (c2 = 5.391 and c2 = 2.228, respectively). Moreover, MVD in gastric cancer tissues was significantly higher than that in the normal mucosa (65.49 +/- 20.64 vs 36.21 +/- 18.47, t/F = 7.53, P < 0. 05). MVD was related to the histologic type and metastasis (t/F = 3.68 and t/F = 4.214, respectively, P < 0. 05), but not related to the depth of invasion and Borrmann type (t/F = 0.583 and t/F = 0.459, respectively). MVD in COX-2-positive tissues was markedly higher compared to COX-2-negative tissues, indicating a positive correlation between COX-2 expression and MVD (t = 13.12, P < 0. 05). CONCLUSION: Tissue microarray (TMA) is a powerful tool for rapid identification of the molecular alterations in gastric cancer. COX-2 expression, via inducing angiogenesis, may play an important role in gastric carcinogenesis. It could be served as a determinant factor for clinical prognosis and curative effect.
AIM: To explore the expression and clinicopathological significance of cyclooxygenase-2 (COX-2) and microvessel density (MVD) in gastric carcinogenesis, and to investigate their roles in the invasion and the relationship between biological behaviors and prognosis of gastric cancer. METHODS: Using Envision immunohistochemistry, COX-2 and CD34 expressions in gastric cancer tissue array were examined. MVD was counted and the relationship between the biological behaviors and prognosis was analyzed. RESULTS: The expression of COX-2 in gastric cancer tissue was significantly higher than that in normal mucosa (c2 = 12.191, P < 0.05). The over-expression of COX-2 in gastric cancer was obviously related to metastasis and depth of invasion (c2 = 6.315, P < 0.05), but not related to the histological type and Borrmann type (c2 = 5.391 and c2 = 2.228, respectively). Moreover, MVD in gastric cancer tissues was significantly higher than that in the normal mucosa (65.49 +/- 20.64 vs 36.21 +/- 18.47, t/F = 7.53, P < 0. 05). MVD was related to the histologic type and metastasis (t/F = 3.68 and t/F = 4.214, respectively, P < 0. 05), but not related to the depth of invasion and Borrmann type (t/F = 0.583 and t/F = 0.459, respectively). MVD in COX-2-positive tissues was markedly higher compared to COX-2-negative tissues, indicating a positive correlation between COX-2 expression and MVD (t = 13.12, P < 0. 05). CONCLUSION: Tissue microarray (TMA) is a powerful tool for rapid identification of the molecular alterations in gastric cancer. COX-2 expression, via inducing angiogenesis, may play an important role in gastric carcinogenesis. It could be served as a determinant factor for clinical prognosis and curative effect.
Authors: Seth C Gamradt; Brian T Feeley; Nancy Q Liu; Jason Roostaeian; Ying Q Lin; Li X Zhu; Sherven Sharma; Steven M Dubinett; Jay R Lieberman Journal: Anticancer Res Date: 2005 Jan-Feb Impact factor: 2.480
Authors: H Y Lim; H J Joo; J H Choi; J W Yi; M S Yang; D Y Cho; H S Kim; D K Nam; K B Lee; H C Kim Journal: Clin Cancer Res Date: 2000-02 Impact factor: 12.531
Authors: R Ohno; K Yoshinaga; T Fujita; K Hasegawa; H Iseki; H Tsunozaki; W Ichikawa; Z Nihei; K Sugihara Journal: Cancer Date: 2001-05-15 Impact factor: 6.860
Authors: Claus L Andersen; Outi Monni; Urs Wagner; Juha Kononen; Maarit Bärlund; Christoph Bucher; Philippe Haas; Antonio Nocito; Heidi Bissig; Guido Sauter; Anne Kallioniemi Journal: Am J Pathol Date: 2002-07 Impact factor: 4.307
Authors: M S Al-Moundhri; I Al-Hadabi; K Al-Mawaly; S Kumar; F A R Al-Lawati; G Bhatnager; S Kuruvila; A Al-Hamdani; S M El-Sayed; B Al-Bahrani Journal: Med Oncol Date: 2011-11-03 Impact factor: 3.064
Authors: Corinne M Doll; Kathryn Winter; David K Gaffney; Janice K Ryu; Anuja Jhingran; Adam P Dicker; Joanne B Weidhaas; Brigitte E Miller; Anthony M Magliocco Journal: Int J Gynecol Cancer Date: 2013-01 Impact factor: 3.437
Authors: Agnieszka Korga; Marta Ostrowska; Magdalena Iwan; Małgorzata Skierucha; Aleksandra Józefczyk; Piotr Pawłowski; Jarosław Dudka; Ryszard Maciejewski; Robert Sitarz Journal: Food Nutr Res Date: 2019-06-25 Impact factor: 3.894